Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Sony Group Corp (SONY) Price & Performance

AbCellera Biologics IncTrade
Sony Group CorpTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Sony Group Corp — how do they compare? AbCellera Biologics Inc trades at $8.99 (market cap $2.99B), while Sony Group Corp trades at $23.58 (market cap $138.43B). The key difference: Sony Group Corp is far larger — about 46.3× AbCellera Biologics Inc's market cap, and Sony Group Corp pays a 0.67% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLSONY
Market Cap
$2.99B$138.43B
Sector
HealthTechnology
52-Week High
$9.76$30.26
52-Week Low
$2.78$19.32
Enterprise Value
$2.58B$136.35B
Dividend Yield
0.67%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Sony Group Corp

Sony Group is a conglomerate with consumer electronics roots, which not only designs, develops, produces, and sells electronic equipment and devices, but also is engaged in content businesses, such as console and mobile games, music, and movies. Sony is a global top company of CMOS image sensors, game consoles, professional broadcasting cameras, and music publishing, and is one of the top players on digital cameras, wireless earphones, recorded music, movies, and so on. Sony's business portfolio is well diversified with six major business segments. The company fully consolidated Sony Financial in September 2020, which provides life and non-life insurance, banking, and other financial services.

Read more on SONY